Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price traded down 0.5% on Tuesday . The company traded as low as $1.92 and last traded at $1.93. 4,774,146 shares changed hands during trading, a decline of 85% from the average session volume of 31,012,432 shares. The stock had previously closed at $1.94.
Analyst Ratings Changes
A number of research analysts have recently issued reports on the company. Canaccord Genuity Group dropped their price objective on Tilray from $4.25 to $4.00 and set a "buy" rating on the stock in a research note on Wednesday, April 10th. CIBC cut their price target on Tilray from $2.25 to $2.00 and set a "neutral" rating on the stock in a report on Wednesday, April 10th. Finally, Alliance Global Partners raised their price objective on shares of Tilray from $2.25 to $2.75 and gave the stock a "neutral" rating in a research report on Friday, April 5th.
Read Our Latest Report on TLRY
Tilray Stock Down 1.5 %
The stock has a 50-day moving average of $2.05 and a 200 day moving average of $1.96. The company has a market capitalization of $1.48 billion, a PE ratio of -4.34 and a beta of 2.36. The company has a quick ratio of 1.18, a current ratio of 1.92 and a debt-to-equity ratio of 0.11.
Hedge Funds Weigh In On Tilray
Institutional investors have recently bought and sold shares of the company. Clear Street Markets LLC bought a new stake in shares of Tilray in the third quarter valued at approximately $25,000. Gainplan LLC purchased a new stake in shares of Tilray during the fourth quarter worth $28,000. Simplicity Wealth LLC bought a new position in shares of Tilray in the first quarter worth $28,000. RPO LLC purchased a new position in shares of Tilray in the fourth quarter valued at $28,000. Finally, Great Valley Advisor Group Inc. bought a new stake in shares of Tilray during the 3rd quarter valued at $29,000. Hedge funds and other institutional investors own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
See Also
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
